Form 4 for IRON Disc Medicine, Inc.
Accepted 2024-01-12 00:00:00 ET · period of report 2024-01-10 · accession 0001209191-24-001540 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-12 | 2024-01-10 | IRON | Atlas Venture Associates Opportunity I, L.P. | 10% | S - Sale | $64.00 | -30.0K | 1.45M | -2% | -$1.92M | |
| I | 2024-01-12 | 2024-01-10 | IRON | Atlas Venture Associates Opportunity I, L.P. | 10% | S - Sale | $64.00 | -20.0K | 786.2K | -2% | -$1.28M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-10 | S | D | 30,000 | $64.00 | 1,449,686 | D See footnote | — | — | (F1) These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas X"). Atlas Venture Associates X, L.P. ("Associates X") is the general partner of Atlas X. Atlas Venture Associates X, LLC ("Associates X LLC") is the general partner of Associates X. Each of Associates X and Associates X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas X, except to the extent of its pecuniary interest therein, if any. (F2) These shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Opportunity I"). Atlas Venture Associates Opportunity I, L.P. ("Associates I") is the general partner of Atlas Opportunity I. Atlas Venture Associates Opportunity I, LLC ("Associates I LLC") is the general partner of Associates I. Each of Associates I and Associates I LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Opportunity I, except to the extent of its pecuniary interest therein, if any. |
| 2 | Common | Common Stock | 2024-01-10 | S | D | 20,000 | $64.00 | 786,160 | I | — | — |